Blood and Anemia Management: Saving Scarce Resources and Protecting Critically Ill Patients

Bonus Session Available in Congress Digital

Location: Congress Digital

CE: 1.0

Bonus CE Session Moderator(s)

WM

William Miles, MD, FCCM (he/him/his)

Director of Surgical Critical Care Outreach, Co-Director NeuroSurgical ICU
Carolinas Medical Center
Matthews, North Carolina
ER

Erin Roach, PharmD

Carolinas Medical Center
Charlotte, North Carolina

Most ICU patients are anemic. Anemia is associated with worse outcomes and a necessity for red blood cell transfusion. ICU patients are a heterogeneous group with a broad spectrum of main diagnoses and comorbidities. Evidence-based transfusion trigger guidelines have been established and are dependent on comorbidities. Special attention has been paid to blood-saving measures and point-of-care diagnosis of coagulation disorders in ICU patients. This session will delve into the latest updates on transfusion measures and anemia management to protect patients at their most critical time. New blood product information is evidence-based around whole blood and alternatives when this resource is limited. The use of plasma for the prevention and treatment of coagulopathy and the reversal of anticoagulants will be highlighted.

Learning Objectives:

List the most common causes of anemia in the ICU and how to prevent and manage anemia once it occurs
Evaluate some of the new blood products that can be administered in the critically ill and alternatives when blood is not available
Recognize the indications for plasma transfusion in critically ill patients whether a coagulopathy is physiologic or pharmacologic

Presentations:

It's Not All Bats and Vampires: Anemia Management and Transfusion Alternatives for the Critically Ill
Whole Blood or No Blood: What Makes a Difference in Rapid Resuscitation of Traumatic Hemorrhage?
To Clot or Not to Clot, That Is the Question: Plasma Transfusions for the Critically Ill